Thirdly, factors of MetS (including hyperinsulinemia and blood glucose status at baseline) and medications of DN such as angiotensin converting enzyme inhibitor/angiotensin II receptor blocker and statin might confound the relationship between SUA and diabetic vascular complications and mortality. This evidence concerns the gene ACE and metabolic syndrome.